- Today
- Holidays
- Birthdays
- Reminders
- Cities
- Atlanta
- Austin
- Baltimore
- Berwyn
- Beverly Hills
- Birmingham
- Boston
- Brooklyn
- Buffalo
- Charlotte
- Chicago
- Cincinnati
- Cleveland
- Columbus
- Dallas
- Denver
- Detroit
- Fort Worth
- Houston
- Indianapolis
- Knoxville
- Las Vegas
- Los Angeles
- Louisville
- Madison
- Memphis
- Miami
- Milwaukee
- Minneapolis
- Nashville
- New Orleans
- New York
- Omaha
- Orlando
- Philadelphia
- Phoenix
- Pittsburgh
- Portland
- Raleigh
- Richmond
- Rutherford
- Sacramento
- Salt Lake City
- San Antonio
- San Diego
- San Francisco
- San Jose
- Seattle
- Tampa
- Tucson
- Washington
Lakewood Today
By the People, for the People
Mesa Laboratories Appoints New President and CEO
Siddhartha Kadia to lead the company's next chapter after Gary Owens steps down
Published on Mar. 9, 2026
Got story updates? Submit your updates here. ›
Mesa Laboratories, Inc., a global leader in life science tools and quality control solutions, announced that Gary Owens will step down as President and CEO on April 12, 2026. The Board of Directors has appointed Dr. Siddhartha Kadia as the new President and Chief Executive Officer, effective April 13, 2026. Dr. Kadia will also join the Board.
Why it matters
The leadership transition at Mesa Laboratories comes at a critical time for the company as it looks to build on its strong foundation and continue delivering long-term value for its customers, employees, and shareholders. Dr. Kadia's proven track record of scaling life sciences businesses and commercializing innovative technologies is expected to be crucial for Mesa's next chapter.
The details
Gary Owens has served as Mesa's CEO since 2017, leading the company through a period of significant growth, expansion into new markets, and the implementation of The Mesa Way business system. The Board of Directors has appointed Dr. Siddhartha Kadia, a proven global executive with deep experience in the life sciences industry, as the new President and CEO. Dr. Kadia most recently served as CEO of Calibre Scientific and previously led PhenomeX (formerly Berkeley Lights). He has also held senior leadership roles at EAG Laboratories, Life Technologies, and McKinsey & Company.
- Gary Owens will step down as President and CEO on April 12, 2026.
- Dr. Siddhartha Kadia will assume the role of President and Chief Executive Officer, effective April 13, 2026.
The players
Gary Owens
The outgoing President and CEO of Mesa Laboratories, who has led the company since 2017.
Dr. Siddhartha Kadia
The incoming President and Chief Executive Officer of Mesa Laboratories, who has a proven track record of scaling life sciences businesses and commercializing innovative technologies.
John Sullivan
The Chair of the Board of Directors at Mesa Laboratories.
What they’re saying
“Gary has served as Mesa's CEO since 2017, leading Mesa through a period of significant growth, expansion into new markets, the maturation of the company's foundation, and the implementation of The Mesa Way business system. We are grateful for his leadership and wish him continued success.”
— John Sullivan, Chair of the Board (Globe Newswire)
“Siddhartha is a proven global executive with deep experience scaling life sciences businesses. His track record of commercializing innovative technologies and leading complex organizations makes him the right leader for Mesa's next chapter.”
— John Sullivan, Chair of the Board (Globe Newswire)
“I am honored to join Mesa at this important time. I look forward to working with the talented team to build on the Company's strong foundation and continue delivering long-term value for our customers, employees, and shareholders.”
— Dr. Siddhartha Kadia (Globe Newswire)
What’s next
The leadership transition is expected to be smooth, with Gary Owens stepping down on April 12, 2026, and Dr. Siddhartha Kadia assuming the role of President and CEO on April 13, 2026.
The takeaway
The appointment of Dr. Siddhartha Kadia as the new President and CEO of Mesa Laboratories signals the company's commitment to building on its strong foundation and continuing to deliver innovative life science tools and quality control solutions to its customers worldwide.


